{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:25:30Z","timestamp":1791876330698,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1124\/jpet.111.191353","type":"journal-article","created":{"date-parts":[[2012,2,11]],"date-time":"2012-02-11T05:31:44Z","timestamp":1328938304000},"page":"396-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Phosphodiesterase 9A Regulates Central cGMP and Modulates Responses to Cholinergic and Monoaminergic Perturbation In Vivo"],"prefix":"10.1016","volume":"341","author":[{"given":"Robin J.","family":"Kleiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Chapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curt","family":"Christoffersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari R.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran F.","family":"Geoghegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Grimwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Guanowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mih\u00e1ly","family":"Haj\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geralyn P.","family":"Kocan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Majchrzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"McGinnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stafford","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank S.","family":"Menniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Roof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne W.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane T.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis David","family":"Tingley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Vanase-Frawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Verhoest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.191353_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-2999(90)90240-7","article-title":"Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP","volume":"181","author":"Altar","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.191353_bib2","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.1523\/JNEUROSCI.21-22-09068.2001","article-title":"Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain","volume":"21","author":"Andreeva","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.111.191353_bib3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.neuropharm.2004.07.040","article-title":"Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance","volume":"47","author":"Boess","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.111.191353_bib4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.wnp.0000218991.99714.ee","article-title":"Sensory gating deficit assessed by P50\/Pb middle latency event related potential in Alzheimer's disease","volume":"23","author":"Cancelli","year":"2006","journal-title":"J Clin Neurophysiol"},{"key":"10.1124\/jpet.111.191353_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02815117","article-title":"Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid \u03b2 peptide","volume":"35","author":"Chalimoniuk","year":"1998","journal-title":"Mol Chem Neuropathol"},{"key":"10.1124\/jpet.111.191353_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuroscience.2007.01.025","article-title":"Single unit and population responses during inhibitory gating of striatal activity in freely moving rats","volume":"146","author":"Cromwell","year":"2007","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.111.191353_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jchemneu.2006.02.006","article-title":"The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord","volume":"31","author":"de Vente","year":"2006","journal-title":"J Chem Neuroanat"},{"key":"10.1124\/jpet.111.191353_bib8","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1021\/jm040889k","article-title":"trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists","volume":"48","author":"Di Stefano","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.111.191353_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.111.191353_bib10","doi-asserted-by":"crossref","first-page":"15559","DOI":"10.1074\/jbc.273.25.15559","article-title":"Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase","volume":"273","author":"Fisher","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.111.191353_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.111.191353_bib12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1124\/jpet.104.076968","article-title":"The selective \u03b17 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats","volume":"312","author":"Haj\u00f3s","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.191353_bib13","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1523\/JNEUROSCI.2259-06.2006","article-title":"Tonic and phasic nitric oxide signals in hippocampal long-term potentiation","volume":"26","author":"Hopper","year":"2006","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.111.191353_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0166-4328(02)00285-1","article-title":"Dopamine gating of glutamatergic sensorimotor and incentive motivational input signals to the striatum","volume":"137","author":"Horvitz","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.111.191353_bib15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neuropharm.2011.05.009","volume":"61","author":"Hutson","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.111.191353_bib16","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/jpet.111.191353_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0074-7742(06)78003-5","article-title":"N-methyl-d-aspartate receptors, and dopamine-glutamate interactions","volume":"78","author":"Javitt","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/jpet.111.191353_bib18","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1176\/appi.ajp.158.8.1319","article-title":"Sensory gating deficit expressed by a disturbed suppression of the P50 event-related potential in patients with Alzheimer's disease","volume":"158","author":"Jessen","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1124\/jpet.111.191353_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1023\/A:1014775008533","article-title":"The molecular biology of memory storage: a dialog between genes and synapses","volume":"21","author":"Kandel","year":"2001","journal-title":"Biosci Rep"},{"key":"10.1124\/jpet.111.191353_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jalz.2010.05.1922","article-title":"Dendritic spine density deficits in the hippocampal CA1 region of young Tg2576 mice are ameliorated with the PDE9A inhibitor PF-04447943","volume":"6","author":"Kleiman","year":"2010","journal-title":"Alzheimer's Dementia"},{"key":"10.1124\/jpet.111.191353_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0006-3223(02)01463-4","article-title":"Auditory sensory gating in hippocampus and reticular thalamic neurons in anesthetized rats","volume":"53","author":"Krause","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.111.191353_bib22","unstructured":"McGinnis D, Majchrzak MJ, Guanowsky V, Seymour PA (2010) Development of an NMDA antagonist-disrupted radial arm maze working memory task in rats, at the Society for Neuroscience Annual Meeting; 2010 Nov 13\u201317; San Diego, CA. Abstract 571.18. Society for Neuroscience, Washington, DC."},{"key":"10.1124\/jpet.111.191353_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0920-9964(08)70122-1","article-title":"PDE9A-mediated regulation of cGMP: impact on synaptic plasticity","volume":"102","author":"Menniti","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1124\/jpet.111.191353_bib24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1124\/jpet.109.156919","article-title":"Phosphodiesterase 5A inhibitors improve functional recovery after stroke in rats: optimized dosing regimen with implications for mechanism","volume":"331","author":"Menniti","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.191353_bib25","doi-asserted-by":"crossref","first-page":"P330","DOI":"10.1016\/j.jalz.2009.04.553","article-title":"PF-04447943, a novel PDE9A inhibitor, increases cGMP levels in cerebrospinal fluid: translation from non-clinical species to healthy human volunteers","volume":"5","author":"Nicholas","year":"2009","journal-title":"Alzheimer's Dementia"},{"key":"10.1124\/jpet.111.191353_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002130100763","article-title":"Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?","volume":"156","author":"Ouagazzal","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.111.191353_bib27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.psychres.2007.02.009","article-title":"P50 sensory gating ratios in schizophrenics and controls: a review and data analysis","volume":"158","author":"Patterson","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1124\/jpet.111.191353_bib28","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1124\/jpet.111.191353_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002130050333","article-title":"Inbred strain differences in prepulse inhibition of the mouse startle response","volume":"132","author":"Paylor","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.111.191353_bib30","first-page":"125","article-title":"Purification of PDE6 isozymes from mammalian retina","volume":"307","author":"Pentia","year":"2005","journal-title":"Methods in Molecular Biology"},{"key":"10.1124\/jpet.111.191353_bib31","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1124\/jpet.110.166710","article-title":"Behavioral indices in antipsychotic drug discovery","volume":"333","author":"Porsolt","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.191353_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(01)01614-4","article-title":"cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation","volume":"436","author":"Prickaerts","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.191353_bib33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.neuint.2004.03.022","article-title":"Phosphodiesterase type 5 inhibition improves early memory consolidation of object information","volume":"45","author":"Prickaerts","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1124\/jpet.111.191353_bib34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0306-4522(02)00199-9","article-title":"Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat","volume":"113","author":"Prickaerts","year":"2002","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.111.191353_bib35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1515\/REVNEURO.2006.17.5.497","article-title":"Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease","volume":"17","author":"Puzzo","year":"2006","journal-title":"Rev Neurosci"},{"key":"10.1124\/jpet.111.191353_bib36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/NDT.S2447","article-title":"Role of phosphodiesterase 5 in synaptic plasticity and memory","volume":"4","author":"Puzzo","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1124\/jpet.111.191353_bib37","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1523\/JNEUROSCI.0864-09.2009","article-title":"Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-\u03b2 load in an Alzheimer's disease mouse model","volume":"29","author":"Puzzo","year":"2009","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.111.191353_bib38","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1523\/JNEUROSCI.5291-04.2005","article-title":"Amyloid-\u03b2 peptide inhibits activation of the nitric oxide\/cGMP\/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity","volume":"25","author":"Puzzo","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.111.191353_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2006.11.041","article-title":"Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors","volume":"558","author":"Rutten","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.191353_bib40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-0447.2007.01141.x","article-title":"P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia","volume":"117","author":"S\u00e1nchez-Morla","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"10.1124\/jpet.111.191353_bib41","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/jpet.107.132910","article-title":"Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia","volume":"325","author":"Schmidt","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.191353_bib42","doi-asserted-by":"crossref","first-page":"P331","DOI":"10.1016\/j.jalz.2009.04.554","article-title":"PDE9A-mediated regulation of cGMP: developing a biomarker for a novel therapy for Alzheimer's disease","volume":"5","author":"Schmidt","year":"2009","journal-title":"Alzheimer's Dementia"},{"key":"10.1124\/jpet.111.191353_bib43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jalz.2011.05.2009","article-title":"PF-04447943: a phase II controlled clinical trial of a selective PDE9A inhibitor in Alzheimer's disease","volume":"7","author":"Schwam","year":"2011","journal-title":"Alzheimer's Dementia"},{"key":"10.1124\/jpet.111.191353_bib44","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archpsyc.1984.01790170081009","article-title":"Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses","volume":"41","author":"Siegel","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/jpet.111.191353_bib45","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1369\/jhc.2009.953471","article-title":"Immunohistochemical localization of phosphodiesterase 2A in multiple mammalian species","volume":"57","author":"Stephenson","year":"2009","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/jpet.111.191353_bib46","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.1523\/JNEUROSCI.1902-09.2009","article-title":"More than a retrograde messenger: nitric oxide needs two cGMP pathways to induce hippocampal long-term potentiation","volume":"29","author":"Taqatqeh","year":"2009","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.111.191353_bib47","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neurobiolaging.2008.05.002","article-title":"P50 gating deficit in Alzheimer dementia correlates to frontal neuropsychological function","volume":"31","author":"Thomas","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.1124\/jpet.111.191353_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(03)00082-0","article-title":"The midlatency auditory evoked potential P50 is abnormal in Huntington's disease","volume":"212","author":"Uc","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1124\/jpet.111.191353_bib49","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1460-9568.1995.tb00673.x","article-title":"Age-related changes in the NMDA receptor\/nitric oxide\/cGMP pathway in the hippocampus and cerebellum of freely moving rats subjected to transcerebral microdialysis","volume":"7","author":"Vallebuona","year":"1995","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.111.191353_bib50","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuropharm.2008.07.005","article-title":"The novel selective PDE9 inhibitor BAY 73\u20136691 improves learning and memory in rodents","volume":"55","author":"van der Staay","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.111.191353_bib51","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2008.10.027","article-title":"Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion","volume":"600","author":"van Donkelaar","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.191353_bib52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/01677063.2011.630494","article-title":"The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 attenuates a scopolamine-induced deficit in a novel rodent attention task","volume":"25","author":"Vardigan","year":"2011","journal-title":"J Neurogenet"},{"key":"10.1124\/jpet.111.191353_bib53","doi-asserted-by":"crossref","first-page":"7946","DOI":"10.1021\/jm9015334","article-title":"Identification of a brain penetrant PDE9A inhibitor utilizing prospective design and chemical enablement as a rapid lead optimization strategy","volume":"52","author":"Verhoest","year":"2009","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.111.191353_bib54","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0149-7634(99)00037-8","article-title":"The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?","volume":"23","author":"Wadenberg","year":"1999","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.111.191353_bib55","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0091-3057(90)90359-P","article-title":"Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats","volume":"35","author":"Ward","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.111.191353_bib56","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1126\/science.1123432","article-title":"Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice","volume":"313","author":"Weisstaub","year":"2006","journal-title":"Science"},{"key":"10.1124\/jpet.111.191353_bib57","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.niox.2004.03.007","article-title":"Neuronal nitric oxide synthase knock-out mice show impaired cognitive performance","volume":"10","author":"Weitzdoerfer","year":"2004","journal-title":"Nitric Oxide"},{"key":"10.1124\/jpet.111.191353_bib58","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1523\/JNEUROSCI.4470-03.2004","article-title":"The nitric oxide-guanylyl cyclase signaling pathway modulates membrane activity states and electrophysiological properties of striatal medium spiny neurons recorded in vivo","volume":"24","author":"West","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.111.191353_bib59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jchromb.2008.12.063","article-title":"Development and validation of an LC-MS\/MS method for quantification of cyclic guanosine 3\u2032,5\u2032-monophosphate (cGMP) in clinical applications: A comparison with a EIA method","volume":"877","author":"Zhang","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418192X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418192X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.191353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T16:45:29Z","timestamp":1739983529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652418192X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S002235652418192X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.191353","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphodiesterase 9A Regulates Central cGMP and Modulates Responses to Cholinergic and Monoaminergic Perturbation In Vivo","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.191353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}